U.S. Trade Distributors Stock News

NYSE:BH.A
NYSE:BH.AHospitality

Is Biglari Holdings (BH.A) Undervalued After Its Recent Rally?

Biglari Holdings stock performance snapshot Biglari Holdings (BH.A) has drawn investor attention after recent share price moves, with the stock last closing at US$1,984.54. Returns show mixed short term performance, with a decline over the past month but gains over the past 3 months. See our latest analysis for Biglari Holdings. For context, Biglari Holdings has seen its share price pull back over the past month, even after a strong 3 month share price return of 28.42% and a 1 year total...
NYSE:BFH
NYSE:BFHConsumer Finance

How Bread Financial’s Q2 2026 Capital Return Moves May Impact Bread Financial Holdings (BFH) Investors

Bread Financial Holdings, Inc. reported second-quarter 2026 results with net interest income of US$1,039 million and net income of US$146 million, while also completing a buyback of 7,343,098 shares for US$551.36 million and declaring a quarterly dividend of US$0.23 per share payable on September 15, 2026. The combination of higher earnings per share, a large completed repurchase that reduced the share count, and continued cash returns through dividends underscores management’s ongoing focus...
NasdaqGS:PI
NasdaqGS:PISemiconductor

3 US Stocks Built For Tariff Driven Supply Chain Shifts

The latest round of Section 301 and Section 338 tariffs is prompting investors to reconsider how exposed portfolios are to complex global supply chains. Higher duties, extra compliance checks and uncertain trade rules can all squeeze margins or re-route production closer to home. That is where a curated US manufacturing and onshoring screener can help focus attention. It filters for larger, financially healthy companies with operations rooted in North America. In this article, you will see...
NasdaqGS:TRS
NasdaqGS:TRSPackaging

The Bull Case For TriMas (TRS) Could Change Following Upbeat Guidance And Capital Return Push - Learn Why

TriMas Corporation’s recent second-quarter and six-month 2026 results showed slightly higher sales of US$174.58 million and US$342.86 million respectively, alongside lower quarterly net income of US$13.37 million but a very large six‑month net income of US$814.2 million, while continuing its share repurchase program and affirming a US$0.0400 quarterly dividend. Beneath the headline numbers, the combination of improved profitability from continuing operations, a long-running buyback that has...
NYSE:JXN
NYSE:JXNDiversified Financial

Is Jackson Financial (JXN) Below Fair Value On Its CEO And CFO Transition?

Jackson Financial (JXN) is entering a planned leadership transition that will place longtime finance executive Don W. Cummings in the Chief Executive Officer role and elevate Brian M. Walta to Chief Financial Officer. See our latest analysis for Jackson Financial. Jackson Financial’s leadership reshuffle arrives during a period of strong stock momentum, with a 30 day share price return of 16.98%, year to date share price return of 13.79%, and a 1 year total shareholder return of 50.40%,...
NYSE:TFX
NYSE:TFXMedical Equipment

How FDA Approval of First Freeze Dried Plasma Platform Will Impact Teleflex (TFX) Investors

Teleflex Incorporated recently received U.S. FDA Biologics License Application approval for EZPLAZ Freeze Dried Plasma, the first FDA-licensed freeze dried plasma for adult transfusions when conventional plasma products are unavailable. This approval gives Teleflex its first biologics license for a blood component and introduces a patented flexible bag format that addresses battlefield and prehospital trauma care logistics. We’ll now examine how this first-of-its-kind FDA-approved freeze...
NasdaqGS:CFFN
NasdaqGS:CFFNBanks

What Capitol Federal Financial (CFFN)'s Strong Q3 Results and Completed Buyback Mean For Shareholders

Capitol Federal Financial, Inc. recently reported third-quarter 2026 results, including US$53.48 million in net interest income, US$23.57 million in net income, minimal net charge-offs of US$148,000, completion of a 9,976,478-share buyback totaling US$72.84 million, and reaffirmed a US$0.085 quarterly dividend per share. Together, higher net interest income, growing net income and the completed share repurchase program underscore management’s clear emphasis on capital return and operating...
NasdaqGS:MCBS
NasdaqGS:MCBSBanks

MetroCity Bankshares (MCBS) Earnings Drew Interest, Is The Stock Still Cheap?

MetroCity Bankshares earnings trigger fresh interest MetroCity Bankshares (MCBS) has drawn investor attention after reporting second quarter 2026 results, with net interest income of $44.04 million and net income of $22.13 million, both higher than the prior year period. See our latest analysis for MetroCity Bankshares. MetroCity Bankshares has seen mixed trading around the earnings release, with the share price slipping 4.09% over the past month but still posting a 34.68% year to date share...
NasdaqGS:BUSE
NasdaqGS:BUSEBanks

First Busey (BUSE) Earnings Jumped And Buybacks Ended, Is The Stock Fairly Valued?

Why First Busey’s latest earnings and buyback matter for investors First Busey (BUSE) has drawn fresh attention after second quarter and year to date results showed much higher net income and earnings per share, alongside the completion of a multi year share repurchase program. See our latest analysis for First Busey. At a share price of $30.86, First Busey has delivered a 15.97% 90 day share price return and a 45.10% 1 year total shareholder return, which indicates that recent earnings and...
NasdaqGM:ETON
NasdaqGM:ETONPharmaceuticals

Eton Pharmaceuticals (ETON) Files For Pediatric Label Expansion, Is The Stock Fully Priced?

Eton Pharmaceuticals (ETON) has filed a Prior Approval Supplement with the U.S. Food and Drug Administration to expand KHINDIVI’s label to younger pediatric patients, following bioequivalence data versus ALKINDI SPRINKLE hydrocortisone granules. See our latest analysis for Eton Pharmaceuticals. The KHINDIVI label expansion filing comes after a very strong run in Eton Pharmaceuticals’ stock, with a 30 day share price return of 26.73%, a 90 day share price return of 60.62% and a year to date...
NasdaqGS:MYGN
NasdaqGS:MYGNBiotechs

Why Myriad Genetics (MYGN) Is Down 49.0% After Cutting 2026 Revenue Outlook On Prenatal Weakness

In late July 2026, Myriad Genetics reported second-quarter results showing revenue of US$190.7 million versus US$213.1 million a year earlier, alongside a reduced full-year 2026 revenue outlook of US$770 million to US$790 million due to weaker Prenatal Health test volumes and more cautious assumptions for revenue per test. Despite the revenue decline, the company’s net loss narrowed sharply to US$43.2 million from a very large loss a year ago, highlighting significant cost or non-operational...
NYSE:H
NYSE:HHospitality

Hyatt Hotels (H) Updates Guidance And Buybacks, Is The Stock Still Undervalued?

Q2 results and capital return actions in focus for Hyatt Hotels stock Hyatt Hotels (H) has drawn investor attention after its second quarter 2026 earnings, the Board-approved third quarter dividend, an updated full-year net income outlook, and progress on a multi-year share repurchase program. See our latest analysis for Hyatt Hotels. Despite Q2 earnings, guidance and capital returns in focus, Hyatt Hotels shares have pulled back recently, with the 30 day share price return down 8.8% and the...
NasdaqGS:CORZ
NasdaqGS:CORZSoftware

Why Core Scientific (CORZ) Is Down 8.9% After Massive AMD AI Data Center Deal And $1.16 Billion Loss

In late July 2026, Core Scientific, Inc. reported Q2 2026 revenue of US$164.2 million alongside a net loss of US$1.16 billion, and announced a large‑scale AI infrastructure partnership with Advanced Micro Devices, Inc. involving up to 2.5 gigawatts of potential data center capacity and related stock warrants for Advanced Micro Devices, Inc. Core Scientific, Inc. also added veteran technology executive Mark W. Adams to its expanded seven‑member Board of Directors, strengthening oversight as...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

ANI Pharmaceuticals Stock And 2 U.S. Pharma Names Tied To Tariff Upside

Tariffs on Canadian imports and higher taxes on generic drugs are shaking up expectations for costs and pricing across healthcare. For U.S. specialty pharmaceutical manufacturers, this mix of pressure and opportunity can be important. Some companies may face higher input costs. Others with more domestic production may see a relative edge if imported generics become more expensive. This article explains how the new trade measures could matter for your portfolio and discusses 3 U.S. specialty...
NYSE:PNC
NYSE:PNCBanks

3 US Bank Stocks Worth Watching If The Fed Hikes Rates Again

With the Federal Reserve sounding more hawkish and futures markets pricing a 72% chance of a rate hike by September, many investors are rethinking where they want their money to work. Higher expected yields on safer assets can change the appeal of riskier choices, including Bitcoin and some growth stocks. In this environment, large U.S. value stocks with lower volatility and modest P/E and P/B ratios can look interesting to some investors. This article walks through 3 U.S. large cap value...
NYSE:LOMA
NYSE:LOMABasic Materials

Is Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA) Fully Valued At $11.48?

Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA) came into focus after a recent share price move, with the stock closing at $11.48. Investors may now reassess its longer term return profile. See our latest analysis for Loma Negra Compañía Industrial Argentina Sociedad Anónima. The recent move to a share price of $11.48 comes after a mixed run, with the 90 day share price return of 8.20% set against a year to date decline of 10.87%. The 5 year total shareholder return of...
NYSE:RBC
NYSE:RBCMachinery

RBC Bearings (RBC) Is Down 7.4% After Strong Q1 Results And Double-Digit Q2 Sales Guidance

RBC Bearings Incorporated has reported its fiscal first-quarter 2027 results, with net sales rising to US$519.5 million and net income to US$101.5 million, and has issued second-quarter guidance calling for net sales between US$505.0 million and US$515.0 million, implying double-digit year-over-year growth. The combination of strong Aerospace & Defense demand, broad-based Industrial segment growth, and guidance that points to continued operational momentum highlights how current end-market...
NYSE:CWT
NYSE:CWTWater Utilities

California Water Service Group (CWT) Could Be 3% Undervalued On Q2 Earnings Growth

California Water Service Group (CWT) reported second quarter results that attracted investor attention, with higher sales, net income, and earnings per share compared with the same period a year earlier. See our latest analysis for California Water Service Group. At a share price of $50.11, California Water Service Group has seen a 90 day share price return of 18.3% and a year to date share price return of 16.7%, while the 1 year total shareholder return of 10.8% contrasts with a 5 year total...
NasdaqGS:AMSC
NasdaqGS:AMSCElectrical

Is American Superconductor (AMSC) Undervalued After Its Largest Mining Order Yet?

American Superconductor’s latest mining order puts recent stock performance in focus American Superconductor (AMSC) recently announced a US$25 million turnkey order from a North American utility for a large mining project. This contract is the company’s largest individual mining development order to date. The integrated solution will combine STATCOM technology, capacitor banks, shunt reactors and a 138kV transformer with associated switchgear, protection and control systems. Delivery is...
NasdaqGS:KHC
NasdaqGS:KHCFood

Kraft Heinz Stock And 2 Consumer Names Screening For Tariff Reshoring Exposure

Tariffs on Canadian dairy, alcohol, and autos are reshaping expectations for cross border trade, and that puts the spotlight on U.S. Domestic Manufacturing stocks with direct or indirect exposure to this news. The new 50% tariffs and the risk of retaliation could shift where goods are produced, how supply chains are structured, and which companies gain or lose pricing power. This article looks at three stocks from the U.S. Domestic Manufacturing screener that appear to be positively exposed...
NYSE:LVS
NYSE:LVSHospitality

Does Las Vegas Sands' (LVS) Expanded Buyback Plan Redefine Its Capital Allocation Story?

In July 2026, Las Vegas Sands Corp. reported second-quarter 2026 results showing slightly lower quarterly sales and net income year on year, alongside stronger six-month revenue and earnings, while also affirming a quarterly dividend of US$0.30 per share. At the same time, the company completed a long-running US$8.07 billion buyback program and increased its remaining repurchase authorization to US$6.00 billion through 2029, highlighting an ongoing commitment to returning capital to...